Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4100179
Max Phase: Preclinical
Molecular Formula: C17H13N5O6S
Molecular Weight: 415.39
Molecule Type: Small molecule
Associated Items:
ID: ALA4100179
Max Phase: Preclinical
Molecular Formula: C17H13N5O6S
Molecular Weight: 415.39
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)Nc1cc(-c2nnc(SCc3ccc([N+](=O)[O-])cc3)o2)cc([N+](=O)[O-])c1
Standard InChI: InChI=1S/C17H13N5O6S/c1-10(23)18-13-6-12(7-15(8-13)22(26)27)16-19-20-17(28-16)29-9-11-2-4-14(5-3-11)21(24)25/h2-8H,9H2,1H3,(H,18,23)
Standard InChI Key: FSKSBZVKEVDYFK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 415.39 | Molecular Weight (Monoisotopic): 415.0587 | AlogP: 3.80 | #Rotatable Bonds: 7 |
Polar Surface Area: 154.30 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 11 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.21 | CX Basic pKa: | CX LogP: 3.03 | CX LogD: 3.03 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.34 | Np Likeness Score: -2.09 |
1. Karabanovich G, Němeček J, Valášková L, Carazo A, Konečná K, Stolaříková J, Hrabálek A, Pavliš O, Pávek P, Vávrová K, Roh J, Klimešová V.. (2017) S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents., 126 [PMID:27907875] [10.1016/j.ejmech.2016.11.041] |
Source(1):